chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient initially showed improvement with reduction in her oxygen requirements.  However subsequently she became more hypoxic.  She also developed hypercapnia.  Renal function was initially stable but became progressively worse likely due to poor p.o. intake.  She was given some hydration.  On 6/27 she developed even worsening hypoxemia despite maximal therapy.  She was given morphine for comfort at her daughter's request.  She expired with her daughter at bedside on 6/27/22.
Entire left arm is aching; Injection site is still very tender and sore; This is a spontaneous report received from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route of administration in the left arm on 19Mar2021 at 07:15 (at the age of 36-years-old), as a single dose for COVID-19 immunisation. The patient had no medical history reported. The patient did not have allergies to medications, food, or other products. Concomitant medication included unspecified prenatal medications, but took only occasionally for an unspecified indication from unknown date. The patient previously received flu vaccine (MANUFACTURER UNKNOWN), for an unspecified indication. The patient always had her flu shot and it never hurts. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 19Mar2021, at 22:00, the patient's entire left arm was aching and did not experience regular pain. The pain was throughout her entire left arm and the injection site was very tender and sore till the time of this report. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events vaccination site pain and left arm pain. The clinical outcomes of the events vaccination site pain and left arm pain were not recovered.  Information about lot/batch number cannot be obtained. No further information is expected.
lower mouth, cheeks around the sides of her mouth, down to her chin all feel numb; lower mouth, lower lip, her cheeks around the sides of her mouth, down to her chin all feel tingly; lower mouth swollen; lower lip swollen; cheeks around the sides of her mouth, down to her chin swollen; cheeks around the sides of her mouth, down to her chin all feel numb; This non-serious case was reported by a consumer via call center representative and described the occurrence of numbness oral in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (on an unknown date received 1st dose.).   On 04-AUG-2023 10:30, the patient received the 2nd dose of Shingrix (intramuscular, right arm). On 04-AUG-2023 11:10, 40 min after receiving Shingrix, the patient experienced numbness oral (Verbatim: lower mouth, cheeks around the sides of her mouth, down to her chin all feel numb), tingling mouth (Verbatim: lower mouth, lower lip, her cheeks around the sides of her mouth, down to her chin all feel tingly), swollen mouth (Verbatim: lower mouth swollen), lip swelling (Verbatim: lower lip swollen), cheek swelling (Verbatim: cheeks around the sides of her mouth, down to her chin swollen) and numbness facial (Verbatim: cheeks around the sides of her mouth, down to her chin all feel numb). The outcome of the numbness oral, tingling mouth, swollen mouth, lip swelling, cheek swelling and numbness facial were not resolved.   It was unknown if the reporter considered the numbness oral, tingling mouth, swollen mouth, lip swelling, cheek swelling and numbness facial to be related to Shingrix.     It was unknown if the company considered the numbness oral, tingling mouth, swollen mouth, lip swelling, cheek swelling and numbness facial to be related to Shingrix.   Additional Information: GSK Receipt date: 04-AUG-2023 A reporter reported about herself she received her 2nd dose of Shingrix around 10:30 AM today, 4-AUG-2023, and reports that about 40 minutes after receiving the vaccine, her lower mouth, lower lip, her cheeks around the sides of her mouth, down to her chin all feel numb, swollen and tingly like anesthesia wearing off at the dentist, and she is still feeling all of this now still at 1:42 PM 4-AUG-2023. The patient reported that the area does not look swollen, and she can eat and swallow with no problem, it did not involve her tongue or her neck or below her chin area.  Patient reported that she had no problem with the 1st dose of Shingrix.  The reporter consented to follow up.
This non-serious initial spontaneous case, was received from other health professional on 26-Nov-2017, concerning a male patient of age over 65-year-old. On an unspecified date (reported as 11-15 years ago), the patient was administered with INN Flu Vaccine Seasonal (dose, batch number, manufacturer, trade name, route of administration, anatomical location and expiry date: not reported) at physician office. On unspecified date, after the vaccination, the patient had fever, muscles aches, coughing and dizziness. At the time of this report, the outcome of the events was not reported. The reporter considered the causality of the events as related.
Started feeling mild throat tightness around 5 minutes after vaccination, then 10-15 minutes after vaccination lips felt numb. Client was able to swallow and there was no swelling. Client was monitored for worsening symptoms which did not present, and client refused transport to ER. Client's partner agreed to transport to nearby urgent care for further evaluation, outcome unknown.
Pt. developed some swelling in area of (L) neck/Parotid. In no distress. On 11/6 pt. had some redness at injection site (R) deltiod
on Jan 13, 2021 I developed a rash on my back.  It was a little tender. Then on 1/14th I developed a little more rash on my left side and under my left breast.  The rash is painful.  Diagnosed with Shingles!!
Circle is warm; 1.5 inch diameter red circle; feeling more tired than usual; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Circle is warm), INJECTION SITE ERYTHEMA (1.5 inch diameter red circle) and FATIGUE (feeling more tired than usual) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced INJECTION SITE WARMTH (Circle is warm), INJECTION SITE ERYTHEMA (1.5 inch diameter red circle) and FATIGUE (feeling more tired than usual). At the time of the report, INJECTION SITE WARMTH (Circle is warm), INJECTION SITE ERYTHEMA (1.5 inch diameter red circle) and FATIGUE (feeling more tired than usual) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
DIZZY; FELT TO GET A PANIC ATTACK (HYPERVENTILATE, TIGHTNESS OF CHEST, SHORTNESS OF BREATH); FINGERS STARTED TO GET NUMB (FEELING BECAME WORSE THEN BETTER AND NOT CONSTANT); VOMITING/ THREW UP; NAUSEOUS; FELT WEIRD (FEELING BECAME WORSE THEN BETTER AND NOT CONSTANT); This spontaneous report received from a patient concerned a 27 year old female. The patient's height, and weight were not reported. The patient's past medical history included: brain injury, and other pre-existing medical conditions included: The patient had no known allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 14-SEP-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On 14-SEP-2021, the patient experienced felt weird (feeling became worse then better and not constant). On 14-SEP-2021, the patient experienced nauseous. On 17-SEP-2021, the patient experienced dizzy. On 17-SEP-2021, the patient experienced felt to get a panic attack (hyperventilate, tightness of chest, shortness of breath). On 17-SEP-2021, the patient experienced fingers started to get numb (feeling became worse then better and not constant). On 17-SEP-2021, the patient experienced vomiting/ threw up. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from nauseous, dizzy, vomiting/ threw up, fingers started to get numb (feeling became worse then better and not constant), felt weird (feeling became worse then better and not constant), and felt to get a panic attack (hyperventilate, tightness of chest, shortness of breath). This report was non-serious.
Vaginal bleeding @ 17 years past menopause, was refused treatment at Urgent Care so treated myself by eliminating citrus bioflavonoids and had to substitute alfalfa. Bleeding stopped after weeks later. GI Slowdown a month of upset stomach, poor digestions, very ineffective elimination. All known remedies did not work until it became and acute, life threatening blockage June 10 with over 24 hours of level 10 pain. Losing and regaining consciousness, and inability to move food through my system as it was stuck between stomach and intestines.  Used web site and herbal remedies to force severe vomiting, strained muscles at navel but eventually got food out. Lessened the plan and was able to hydrate.  Stomach easily upset by artificial sweeteners, requires tulsi tea and betaine hydrochloride to digest properly and strained area above navel is chronically tender (maybe a hernia). Unmanageable pain of joints and muscles: rheumatoid arthritis rate of deformity accelerated after vaccine (because of the traumatic event), osteoarthritis that only flared after overwork before now is swollen and very painful upon arising after rest. Dyoxis muscle wasting accelerated to the point of inability in one knee to straighten or bend due to usual bike riding position, or to do any recovery of strength at the gym, can't up my weights. Reynaud's worsened, infections and more likely. Dry mouth is worse. Formerly balanced metabolism  went to weight gain in belly only. Eczema formerly ears and feet only now is whole body.
Throbbing pain L arm-radiating into neck and down arm to hand. Unable to use arm. Nausea and vomiting.
This is a 16 year old male patient who is trach-dependent secondary to an inoperable C1-C2 juvenile pilocytic astrocytoma with significant radiation necrosis and neurologic sequelae.  His vaccination was given 10/16/06 11:00.  Patient developed red, itchy rash the following morning.  He was given IV Benadryl and Atarax with little improvement.  Infectious disease was consulted.  The rash persisted for 3 days, then resolved completely.  No respiratory nor mucosal involvement.  Prior to the rash, he had had about 1 week of nausea, slightly loose stools and a sore throat, and was finishing a course of Ceftazidime and Ciprofloxacin for Pseudomonas tracheitis.  No new medications nor exposures. 12/8/06 Received medical records from hospital which reveal patient was rehospitalized on 11/3/06 for trach reconstruction & decannulation. Was initially dx w/transverse myelitis 12/05 then MRI & biopsy revealed JPA 1/06.  Patient has remained hospitalized from 2/06 first as inpatient then into rehab.  Was scheduled to reenter rehab s/p trach reconstruction.
I was diagnosed with a pulmonary embolism on 5-26-2021. No other factors existed for this to happen other than my vaccine.  I am currently still fighting to recover while on blood thinners. I also developed a severe migraine after the first vaccine which lasted nearly a month and had me on and out of the ER.
The muscle aches were bad, the whole body was aching, and I couldn't get comfortable sleeping. I tried going upstairs to go to a different bed, and when I got up there, I had tunnel vision, dizziness, I passed out and hit my head on the bed. But my blood pressure I think dropped when I was trying to get up the stairs, and I don't think that would've happened if I didn't overexert myself. I've never had a reaction like that to any vaccine. Confused about whether or not to medicate during this vaccination for symptoms.
Vaginal spotting over a 3 week period; I have been in menopause for 11 years and have never had any spotting.
lumps in the armpits, same arm of the injection, sometimes gets it in both; This spontaneous case was reported by a patient and describes the occurrence of AXILLARY MASS (lumps in the armpits, same arm of the injection, sometimes gets it in both) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022J21A, 014C21A and 032B21A) for COVID-19 vaccination.     Patient had no medical history. Patient never had COVID positive test or diagnosis.  Concurrent medical conditions included House dust mite allergy and Allergy to molds.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 16-Jan-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced AXILLARY MASS (lumps in the armpits, same arm of the injection, sometimes gets it in both). At the time of the report, AXILLARY MASS (lumps in the armpits, same arm of the injection, sometimes gets it in both) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Ultrasound scan: didn't turn out to be breast cancer.         Concomitant drugs were not reported. It was reported that patient had lump in armpit sometime in vaccination arm and sometime in both arm. Patient did not experience a similar event in the past and event happened repeatedly 5 times so far. Treatment medications were not provided.
Patient passed out and fell over.  He did not injure himself in the fall.  Was out for 1-2 seconds.  Was a little light headed and weak as he sat in the chair, but was recovered after 15 minutes.  Reported being nervous about needles and failed to eat/drink much earlier in the day.
Flu like symptoms like myalgia, achy head, mental cloudiness; Flu like symptoms like myalgia, achy head, mental cloudiness; Flu like symptoms like myalgia, achy head, mental cloudiness; Flu like symptoms like myalgia, achy head, mental cloudiness; Deep cough; This is a spontaneous report from a non-contactable physician. A female patient of unspecified age received the first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on an unspecified date in Dec2020, in left upper arm like deltoid, for COVID-19 immunization. Medical history and concomitant medications were not reported. On an unspecified date in Dec2020, immediately after receiving the vaccine, the patient experienced a deep cough which came on all of a sudden, followed 31 hours post vaccine by flu like symptoms like myalgias, achy head and mental cloudiness. She was feeling a bit better on 22Dec2020 morning and she was back at work. So, it was like a short couple of hours, maybe 24 hours turnaround. The events were resolving at the time of report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: The Company cannot completely exclude the possible causality between the reported flu like symptoms like myalgias, achy head and mental cloudiness and the administration of the COVID 19 vaccine BNT162B2 based on the plausible temporal association.   The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified, as appropriate.
Vaccine was administered to an individual aged 17 years 9 months. No adverse events occured after administering the vaccine.
Approx 3 mins after vaccine admin, patient felt weak, sweaty and light headed. Patient states he "passed out" for about a minute but quickly regained full alertness. Patient reports feeling 100% better after drinking juice and resting. Patient reports not having any food today prior to vaccine. After 15mins obvs time done, patient reports feeling well enough to leave clinic with partner and go home.
Information has been received from a physician via Company representative concerning to a patient of unknown age and gender. Concurrent and historical conditions were not reported. Concomitant therapies were not provided. On 30-NOV-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (Lot No. K001631, exp. 24-FEB-2017) (dose and site not reported). On an unspecified dates, the GARDASIL vaccine had five temperature excursions: 1172, 416, 80, 336, and 168 hours respectively. The lowest recorded temperature were 30 (-1.111111111 Celsius) and -3 (-3 Celsius) and the highest recorded temperature were 49 (9.444444444 Celsius), 47 (8.333333333 Celsius), 59 (15 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
Rapid heartbeat and  allergic reaction/angioedema and new psoriasis flare. Treatment- corticosteroids, antihistamines.
Patient was given only half dose of Moderna Bivalent Booster. Patient was given wrong dose of Booster.
potential pneumonia; COVID-19 positive; shortness of breath; cough; fever; delirious; taking pants off; couldn't speak; incoherent; would not eat or drink; would not eat; A spontaneous report was received from a consumer concerning a 83-year-old, male patient who received Moderna's COVID-19 Vaccine (mRNA-1273) and developed shortness of breath, cough, fever, delirious, taking pants,off, couldn't speak, incoherent, would not eat or drink.    The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, was not reported.   On 28 Jan 2021, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 (Lot 043L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.    On 30 Jan 2021, the patient developed shortness of breath, cough, fever, delirious, taking pants, off, couldn't speak, incoherent, would not eat or drink.    02 Feb 2021 Patient was admitted into the hospital. Patient tested positive for COVID-19. Patient was on a respirator with potential pneumonia.  Treatment for the event was not provided.   Action taken with mRNA-1273 in response to the event was not reported.   The outcome of the events was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. However , the mRNA-1723 does not contain a virus and with the occurrence of Covid-19 positive test after vaccination, the event of Covid -19 is unlikely related to mRNA-1273.
Headache; Injection site tenderness; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) via unspecified route of administration in the right arm on 18Mar2021 10:15 (at the age of 63-years-old), as a single dose for COVID-19 immunisation. Medical history included atrial fibrillation and other heart issues. The patient did not have any allergies to medications, food, or other products. Concomitant medications included metoprolol (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), furosemide (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN), rivaroxaban (XARELTO) prunus cerasus (TART CHERRY), 'ac' (MANUFACTURER UNKNOWN) all taken for an unknown indication and from an unknown date. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via unspecified route of administration in the left arm on 01Mar2021 08:15 (at the age of 62-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08Mar2021 13:00, the patient had headache, injection site tenderness only if touched/bumped/rubbed for a couple days (not noticeable during normal activities). The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive treatment for the reported events. The clinical outcome of the event headache was recovered on 19Mar2021 (reported as gone next morning); while that of the event injection site tenderness was recovered on an unknown date in Mar2021.  No follow-up attempts are needed. No further information is expected
pt with diagnosis of varicella, only symptoms is rash. denies fever or respiratory  symptoms
back pain; arm was tender; arm was warm; hip pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (back pain), TENDERNESS (arm was tender), FEELING HOT (arm was warm) and ARTHRALGIA (hip pain) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, the patient experienced BACK PAIN (back pain), TENDERNESS (arm was tender), FEELING HOT (arm was warm) and ARTHRALGIA (hip pain). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, BACK PAIN (back pain) and TENDERNESS (arm was tender) had not resolved and FEELING HOT (arm was warm) and ARTHRALGIA (hip pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications reported.
pt recvd MMR & approx 5 min later erythema, swelling, urticaria noted @ site of inject; wheel noted above site of inject also; no resp sx; pt recvd epi & DPH; observed approx 1.5 hrs;
Red itchy welt appeared at injection site on 4/5/21.  Showed a picture to my physician who advised me to submit as adverse reaction. Physician instructed me to apply hydrocortisone ointment to help with itching.
Shingles, was given valacyclovir and lidoderm to clear it up, and it is still unresolved.
fatigue for 2 days, swelling of the arm on the side of the injection, redness spreading around the injection arm (6th day), itchiness in the arm
severe debilitating migraines Nausea Thunder clap headaches Sharp shooting pains in head Dizziness   Started day after shot.  Still happening. Been on sick leave from 2-4-2021 as an Officer  can not take that chance   Nortryptilin  Imitrex